ReCode Therapeutics
ReCode Therapeutics is a genetic medicines company that specializes in mRNA and gene correction therapeutics.
Drug Delivery
📍 Menlo Park, CA
Founded 2015
Current Valuation
$700M
as of 2023-Q3
PRIVATE
ReCode Therapeutics is a genetic medicines company that specializes in mRNA and gene correction therapeutics.
Company Profile
Last Round
Series B — $260M (Sep 2023)
Fundraising Status
Series B · $260M · 2y 9mo ago
privateTotal raised $342M
Latest Funding Round
| Round | Amount | Date | Lead Investor | Post-Money |
|---|
| Series B | $260M | Sep 2023 | — | $700M |
BiopharmaBiotechnologyGeneticsPharmaceutical
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2023-Q3. Refreshed quarterly.